NCT00255645终止不适用
A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- AstraZeneca
- 入组人数
- 4,500
- 试验地点
- 1
研究概览
简要总结
This is a long-term safety follow-up study to assess the post-treatment safety, at 12 and 24 months, in patients with type 2 diabetes after participation in the phaseII/III studies GALLANT, GALLEX and ARMOR. In addition, selected patients, including those with pre-defined laboratory or clinical findings, will have a 12-week post-treatment follow-up visit, including laboratory evaluation and adverse event recording.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Provision of a written informed consent
- •Men or women who either completed at least 6 months in a previous treatment study GALLANT, GALLEX or ARMOR or met a pre-defined laboratory or clinical finding during participation in any of the said studies.
排除标准
- •Received open-label treatment with tesaglitazar (since this is a post-treatment study)
研究者
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
2 期
Long-term Follow-Up Study of RGX-314 and Fellow Eye SubstudyNeovascular Age-related Macular DegenerationWet Macular DegenerationNCT03999801AbbVie865
Enrolling By Invitation
2 期
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMDNeovascular Age-Related Macular Degeneration (nAMD)Gene TherapyWet AMDwAMDnAMDNCT05210803AbbVie116
Enrolling By Invitation
2 期
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic RetinopathyDiabetic Retinopathy, DRNCT05296447AbbVie100
已完成
不适用
Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)Urea Cycle DisordersCrigler Najjar SyndromeNCT02051049Cellaion SA9
已完成
不适用
Retro-prospective Study of Safety & Performance of Round XTENDOBUTTON™ Fixation Device Post Knee RepairKnee ReconstructionNCT04211857Smith & Nephew, Inc.40